TY - JOUR
T1 - Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
AU - Molina, Juan L.
AU - Calvó, María
AU - Padilla, Eduardo
AU - Balda, Mara
AU - Alemán, Gabriela González
AU - Florenzano, Néstor V.
AU - Guerrero, Gonzalo
AU - Kamis, Danielle
AU - Rangeon, Beatriz Molina
AU - Bourdieu, Mercedes
AU - Strejilevich, Sergio A.
AU - Conesa, Horacio A.
AU - Escobar, Javier I.
AU - Zwir, Igor
AU - Cloninger, C. Robert
AU - De Erausquin, Gabriel A.
N1 - Publisher Copyright:
© The Author(s) 2017.
PY - 2017/1/11
Y1 - 2017/1/11
N2 - Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-Term treatment outcomes. We recruited 61 antipsychotic naïve subjects with chronic schizophrenia, 99 unaffected relatives, and 68 healthy controls from rural communities in the Central Andes. Diagnosis was ascertained with the Schedules of Clinical Assessment in Neuropsychiatry; parkinsonian motor impairment was measured with the Unified Parkinson's Disease Rating Scale; mesencephalic parenchyma was evaluated with transcranial ultrasound; and personality traits were assessed using the Temperament and Character Inventory. Ten-year outcome data was available for ∼40% of the index cases. Patients with schizophrenia had higher harm avoidance and self-Transcendence (ST), and lower reward dependence (RD), cooperativeness (CO), and self-directedness (SD). Unaffected relatives had higher ST and lower CO and SD. Parkinsonism reliably predicted RD, CO, and SD after correcting for age and sex. The average duration of untreated psychosis (DUP) was over 5 years. Further, SD was anticorrelated with DUP and antipsychotic dosing at follow-up. Baseline DUP was related to antipsychotic dose-years. Further, â € explosive/borderline', â € methodical/obsessive', and â € disorganized/schizotypal' personality profiles were associated with increased risk of schizophrenia. Parkinsonism predicts core personality features and treatment outcomes in schizophrenia. Our study suggests that RD, CO, and SD are endophenotypes of the disease that may, in part, be mediated by dopaminergic function. Further, SD is an important determinant of treatment course and outcome.
AB - Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-Term treatment outcomes. We recruited 61 antipsychotic naïve subjects with chronic schizophrenia, 99 unaffected relatives, and 68 healthy controls from rural communities in the Central Andes. Diagnosis was ascertained with the Schedules of Clinical Assessment in Neuropsychiatry; parkinsonian motor impairment was measured with the Unified Parkinson's Disease Rating Scale; mesencephalic parenchyma was evaluated with transcranial ultrasound; and personality traits were assessed using the Temperament and Character Inventory. Ten-year outcome data was available for ∼40% of the index cases. Patients with schizophrenia had higher harm avoidance and self-Transcendence (ST), and lower reward dependence (RD), cooperativeness (CO), and self-directedness (SD). Unaffected relatives had higher ST and lower CO and SD. Parkinsonism reliably predicted RD, CO, and SD after correcting for age and sex. The average duration of untreated psychosis (DUP) was over 5 years. Further, SD was anticorrelated with DUP and antipsychotic dosing at follow-up. Baseline DUP was related to antipsychotic dose-years. Further, â € explosive/borderline', â € methodical/obsessive', and â € disorganized/schizotypal' personality profiles were associated with increased risk of schizophrenia. Parkinsonism predicts core personality features and treatment outcomes in schizophrenia. Our study suggests that RD, CO, and SD are endophenotypes of the disease that may, in part, be mediated by dopaminergic function. Further, SD is an important determinant of treatment course and outcome.
UR - http://www.scopus.com/inward/record.url?scp=85047084629&partnerID=8YFLogxK
U2 - 10.1038/npjschz.2016.36
DO - 10.1038/npjschz.2016.36
M3 - Article
C2 - 28127577
AN - SCOPUS:85047084629
SN - 2334-265X
VL - 3
JO - npj Schizophrenia
JF - npj Schizophrenia
M1 - 16036
ER -